• Citer

Prognostic factors and prognostic index for chemonaïve and gemcitabine-refractory patients with advanced pancreatic cancer.

par Marechal, Raphaël ;Demols, Anne ;Gay, Frederick;De Maertelaer, Viviane ;Arvanitakis, Marianna ;Hendlisz, Alain ;Van Laethem, Jean-Luc
Référence Oncology, 73, 1-2, page (41-51)
Publication Publié, 2007

Article révisé par les pairs

• Détails
• Contenu

Titre:	Prognostic factors and prognostic index for chemonaïve and gemcitabine-refractory patients with advanced pancreatic cancer.
Auteur:	Marechal, Raphaël; Demols, Anne; Gay, Frederick; De Maertelaer, Viviane; Arvanitakis, Marianna; Hendlisz, Alain; Van Laethem, Jean-Luc
Informations sur la publication:	Oncology, 73, 1-2, page (41-51)
Statut de publication:	Publié, 2007
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Gemcitabine
	Neoplasms
	Pancreas
	Prognosis
MeSH keywords:	Actuarial Analysis
	Adenocarcinoma -- drug therapy -- secondary
	Adult
	Aged
	Aged, 80 and over
	Albumins -- metabolism
	Antimetabolites, Antineoplastic -- therapeutic use
	Aspartate Aminotransferases -- blood
	CA-19-9 Antigen -- blood
	Deoxycytidine -- analogs & derivatives -- therapeutic use
	Disease-Free Survival
	Drug Resistance, Neoplasm
	Female
	Humans
	Karnofsky Performance Status
	Male
	Middle Aged
	Pancreatic Neoplasms -- drug therapy -- pathology
	Predictive Value of Tests
	Prognosis
	Proportional Hazards Models
	Retrospective Studies
	Survival Analysis
	Tumor Markers, Biological -- blood
	Weight Loss
Note générale:	Journal Article
Langue:	Anglais
Identificateurs:	urn:issn:0030-2414
	info:doi/10.1159/000120627
	info:pii/000120627
	info:scp/41549100207
	info:pmid/18334830